Navigation Links
Vapotherm Closes Financing Round, Appoints James Liken as Chairman of the Board and Opens New Corporate Headquarters
Date:4/24/2013

EXETER, N.H., April 24, 2013 /PRNewswire-USNewswire/ -- On April 12, 2013 Vapotherm closed a $29MM financing round which was led by the 3x5 Special Opportunity Fund L.P. and included new investor Morgenthaler Venture Partners L.P.  Existing investors GE Asset Management, Kaiser Permanente, Integral Capital Partners, QuestMark Partners and Cross Creek Capital also participated in the current round. The proceeds from this financing will be used to fund the Company's growth plans.

Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund, and Jason Lettmann , Principal of Morgenthaler Venture Partners, both join the Board of Directors.

"We are delighted to be a part of the Vapotherm story," said Tony Arnerich , General Partner of the 3x5 Special Opportunity Fund.  "The unique technology and its clinical benefit for patients with a wide variety of breathing disorders is what appealed to our group. We look forward to supporting the Company and its management team."

James "Jim" Liken, a board member since April 2010, has agreed to serve as Chairman of the Board of Directors.  Jim has extensive experience with respiratory technology companies, including Respironics Inc. where he served as President and CEO from August 1999 through December 2003 and as Vice Chairman until March 2008.

"I have been part of the team for almost three years and am pleased to serve in this new capacity.  This is a very exciting time for Vapotherm," said Jim Liken.

Bill Niland , Founder of Vapotherm said, "We appreciate the support of new investors 3x5 and Morgenthaler and our existing investors, as well as Jim's commitment to serve as Chairman of the Board.  He brings a wealth of knowledge and experience to our organization."

In addition to closing the financing Vapot
'/>"/>

SOURCE Vapotherm, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Aethlon Medical Discloses Cancer and Infectious Disease Therapy Presentation at ISEV 2013
2. InspireMD Closes $25 Million Underwritten Public Offering
3. Inovio Pharmaceuticals Closes $15.1 Million Offering of Common Stock and Warrants
4. PTC Therapeutics Closes $60 Million Private Financing
5. Spring Bank Pharmaceuticals Closes $10.5 million Series A Financing to fund Phase I Clinical Trials in HCV-infected Patients
6. Sphere Fluidics Successfully Closes a $2.5 million Series A Investment Round
7. Aratana Closes $12 Million Series C Financing to Fund Pipeline Expansion
8. Aethlon Medical Discloses CEO Interview
9. Wright Therapy Products, Inc. Closes $3 million Financing Round
10. Synthetic Biologics Closes Deal for Acquisition of C. difficile Infectious Disease Program
11. Edison Pharmaceuticals Closes $20M Series F Financing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... on its pipeline and new product development efforts. In ... initiate a Phase 2a study of AZ-002 (Staccato ... the management of patients with acute repetitive seizures. ... -based product candidates for development - AZ-008 and ...
(Date:7/31/2014)... -- UBM Medica US announces that Cancer Network ... exclusive slide shows dealing with communication in the oncology ... Cancer Network, the online home ... and podcasts about the latest clinical findings. Among the ... , End-of-life care is challenging for even the most ...
(Date:7/31/2014)... 31, 2014  Decision Resources Group,s experts ... by the Affordable Care Act (ACA), which ... pharmaceutical therapies. The ACA altered how Managed ... regulations and expanded access via government-supported programs. ... exchanges—state-based marketplaces set up by states or ...
Breaking Medicine Technology:Alexza Provides Pipeline Update 2Alexza Provides Pipeline Update 3Alexza Provides Pipeline Update 4Alexza Provides Pipeline Update 5Alexza Provides Pipeline Update 6Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 2Cancer Network Highlights Methods Oncologists Can Use to Improve Communication 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4
... Untold Numbers of Consumers Still Left Disabled By Its ... GlaxoSmithKline, the maker of popular denture adhesives Poligrip and Super ... its denture adhesive products.  The pharmaceutical giant has added the potentially ... consuming large quantities of zinc over an extended period of time ...
... , , SHANGHAI , ... WX ), a leading pharmaceutical, biotechnology and medical device R&D outsourcing ... announced that it will release financial results for the fourth quarter of ... 8, 2010 (which will be Tuesday morning, March 9, 2010 ...
Cached Medicine Technology:Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 2Leading Denture Cream Litigation Firm Welcomes GSK Announcement of Removal of Zinc From Its Denture Creams 3WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 2WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release 3
(Date:8/1/2014)... The Judicial Panel on Multidistrict Litigation (JPML) issued ... strokes, heart attacks, and other injuries in men who ... as the transferee judge and ordered what could be ... , As one of his first organizing acts, Judge ... who will move the litigation forward on behalf of ...
(Date:8/1/2014)... Barbara Bronson Gray HealthDay Reporter ... are obese and work in manufacturing jobs may have significantly less ... In a study of 32 people -- half were obese, half ... endurance times that were about 60 percent longer. Obesity also ... performance. Being older -- 50 to 65 years ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 As it ... behalf of women who allegedly experienced the spread of ... in gynecological surgeries, Bernstein Liebhard LLP notes the growing ... number of power morcellators marketed by its Ethicon, Inc. ... The New York Times, some critics of the company ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 On Monday, ... California NextGen User Symposium in San Francisco, CA. Now ... at the JW Marriott Union Square hotel. , “We ... get up to speed with ACA compliance issues,” Quirk ... month. The symposium provides attendees guidance with NextGen implementation ...
Breaking Medicine News(10 mins):Health News:Judge Kennelly Appoints Attorney Michelle Kranz to the Plaintiffs’ Executive Committee in the Testosterone Replacement Therapy MDL 2Health News:Obesity Might Slow You Down at Work 2Health News:Obesity Might Slow You Down at Work 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2
... obstructive sleep apnea (OSA), a sleep disorder associated with ... coronary arteries, according to a study presented today at ... America (RSNA). "Our study reveals that individuals with ... form of atherosclerosis that puts them at risk for ...
... Using functional magnetic resonance imaging (fMRI), researchers have captured ... stimulus with and without acupuncture to determine acupuncture,s effect ... study, which the researchers say suggest the effectiveness of ... the Radiological Society of North America (RSNA). "Until ...
... Whitehead Institute researchers have shown in mouse models that ... leukemia and accelerate the disease,s progression. Their results are ... of the National Academy of Sciences (PNAS). "MicroRNAs ... mice, can upregulation of a microRNA actually cause the ...
... bottle of pomegranate juice at the store because you,ve learned ... replete with antioxidants that bring health benefits. But wait: ... is the product label you have carefully read promising more ... California, Riverside is determined to find out. Cynthia ...
... MONDAY, Nov. 29 (HealthDay News) -- Women have worse ... (PAD) in their lower extremities, a new study has ... for PAD surgery in lower extremities conducted from 1998 ... Of those hospitalizations, 162,730 (43.6 percent) were women. ...
... News) -- Patients who trust that their doctor would tell ... those who doubt their physician would own up to the ... doesn,t mean patients are less likely to sue. Researchers ... about 40 percent had personal experience with medical errors or ...
Cached Medicine News:Health News:People with sleep apnea at higher risk for aggressive heart disease 2Health News:Acupuncture changes brain's perception and processing of pain 2Health News:Tiny RNA shown to cause multiple types of leukemia 2Health News:Tiny RNA shown to cause multiple types of leukemia 3Health News:How authentic is your pomegranate juice? 2Health News:Peripheral Arterial Surgery Outcomes Worse for Women: Study 2Health News:Trust in Doctor May Affect Reaction to Medical Error 2
Irrigating Cystotome, formed, 23 g., 12 mm curved tip. Overall length 14 mm. 5/box....
Peribulbar Needle, 25 g. Atkinson style bevel. Overall length 31 mm. 5/box....
Scleral Blade tip 5700 style, straight. Dimensions: 15.2 mm (L) x 3.4 mm (W). Cut: 2.7 mm....
Blade tip handle....
Medicine Products: